Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease. We work to provide hope for people whose lives are impacted by rare liver diseases, such as Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), a rare growth disorder or rare bone disease. To us, it’s important we put the person living with rare disease first in all that we do. Every day, our more than 5,000 employees worldwide, including nearly 800 in North America, work diligently to improve lives around the world.